Literature DB >> 24319509

Canadian guideline on genetic screening for hereditary renal cell cancers.

M Neil Reaume1, Gail E Graham, Eva Tomiak, Suzanne Kamel-Reid, Michael A S Jewett, Georg A Bjarnason, Normand Blais, Melanie Care, Darryl Drachenberg, Craig Gedye, Ronald Grant, Daniel Y C Heng, Anil Kapoor, Christian Kollmannsberger, Jean-Baptiste Lattouf, Eamonn R Maher, Arnim Pause, Dean Ruether, Denis Soulieres, Simon Tanguay, Sandra Turcotte, Philippe D Violette, Lori Wood, Joan Basiuk, Stephen E Pautler.   

Abstract

BACKGROUND: Hereditary renal cell cancer (RCC) is an ideal model for germline genetic testing. We propose a guideline of hereditary RCC specific criteria to suggest referral for genetic assessment.
METHODS: A review of the literature and stakeholder resources for existing guidelines or consensus statements was performed. Referral criteria were developed by expert consensus.
RESULTS: The criteria included characteristics for patients with RCC (age ≤45 years, bilateral or multifocal tumours, associated medical conditions and non-clear cell histologies with unusual features) and for patients with or without RCC, but a family history of specific clinical or genetic diagnoses.
CONCLUSIONS: This guideline represents a practical RCC-specific reference to allow healthcare providers to identify patients who may have a hereditary RCC syndrome, without extensive knowledge of each syndrome. RCC survivors and their families can also use the document to guide their discussions with healthcare providers about their need for referral. The criteria refer to the most common hereditary renal tumour syndromes and do not represent a comprehensive or exclusive list. Prospective validation of the criteria is warranted.

Entities:  

Year:  2013        PMID: 24319509      PMCID: PMC3854468          DOI: 10.5489/cuaj.1496

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  18 in total

1.  Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development.

Authors:  Berton Zbar; Gladys Glenn; Maria Merino; Lindsay Middelton; James Peterson; Jorge Toro; Jonathan Coleman; Peter Pinto; Laura S Schmidt; Peter Choyke; W Marston Linehan
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

Review 2.  The dermatologist's guide to hereditary syndromes with renal tumors.

Authors:  Pascal G Ferzli; Christian R Millett; Marissa D Newman; Warren R Heymann
Journal:  Cutis       Date:  2008-01

3.  Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.

Authors:  Jessica Clague; Jie Lin; Adrian Cassidy; Surena Matin; Nizar M Tannir; Pheroze Tamboli; Christopher G Wood; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

4.  Concise handbook of familial cancer susceptibility syndromes - second edition.

Authors:  Noralane M Lindor; Mary L McMaster; Carl J Lindor; Mark H Greene
Journal:  J Natl Cancer Inst Monogr       Date:  2008

5.  Genotype-phenotype correlations in von Hippel-Lindau disease.

Authors:  Kai Ren Ong; Emma R Woodward; Pip Killick; Caron Lim; Fiona Macdonald; Eamonn R Maher
Journal:  Hum Mutat       Date:  2007-02       Impact factor: 4.878

6.  Hereditary renal cell carcinoma associated with von Hippel-Lindau disease: a description of a Nova Scotia cohort.

Authors:  Shannon Bradley; Nadine Dumas; Mark Ludman; Lori Wood
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

Review 7.  Uncommon and recently described renal carcinomas.

Authors:  John R Srigley; Brett Delahunt
Journal:  Mod Pathol       Date:  2009-06       Impact factor: 7.842

8.  Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax.

Authors:  Yoko Gunji; Taeko Akiyoshi; Teruhiko Sato; Masatoshi Kurihara; Shigeru Tominaga; Kazuhisa Takahashi; Kuniaki Seyama
Journal:  J Med Genet       Date:  2007-05-11       Impact factor: 6.318

Review 9.  Hereditary kidney cancer: unique opportunity for disease-based therapy.

Authors:  W Marston Linehan; Peter A Pinto; Gennady Bratslavsky; Elizabeth Pfaffenroth; Maria Merino; Cathy D Vocke; Jorge R Toro; Donald Bottaro; Len Neckers; Laura S Schmidt; Ramaprasad Srinivasan
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

Review 10.  Inherited forms of renal cell carcinoma.

Authors:  M Kiuru; M Kujala; K Aittomäki
Journal:  Scand J Surg       Date:  2004       Impact factor: 2.360

View more
  14 in total

1.  Evaluation and screening for hereditary renal cell cancers.

Authors:  W Marston Linehan
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

2.  2018 CUA Abstracts.

Authors: 
Journal:  Can Urol Assoc J       Date:  2018-06       Impact factor: 1.862

3.  Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.

Authors:  Sebastien J Hotte; Anil Kapoor; Naveen S Basappa; Georg Bjarnason; Christina Canil; Henry J Conter; Piotr Czaykowski; Jeffrey Graham; Samantha Gray; Daniel Y C Heng; Pierre I Karakiewicz; Christian Kollmannsberger; Aly-Khan A Lalani; Scott A North; François Patenaude; Denis Soulières; Phillippe Violette; Eric Winquist; Lori A Wood; Shaan Dudani; Ranjena Maloni; M Neil Reaume
Journal:  Can Urol Assoc J       Date:  2019-10       Impact factor: 1.862

4.  Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.

Authors:  Hong Truong; Sarah E Hegarty; Leonard G Gomella; William K Kelly; Edouard J Trabulsi; Costas D Lallas; Veda N Giri
Journal:  J Genet Couns       Date:  2017-01-19       Impact factor: 2.537

5.  Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.

Authors:  Junlong Wu; Hongkai Wang; Christopher J Ricketts; Youfeng Yang; Maria J Merino; Hailiang Zhang; Guohai Shi; Hualei Gan; W Marston Linehan; Yao Zhu; Dingwei Ye
Journal:  Cancer       Date:  2018-12-12       Impact factor: 6.860

6.  Structured assessment and followup for patients with hereditary kidney tumour syndromes.

Authors:  Jean-Baptiste Lattouf; Stephen E Pautler; M Neil Reaume; Raymond H Kim; Melanie Care; Jane Green; Alan So; Philippe D Violette; Issam Saliba; Philippe Major; Shane Silver; Richard Leicht; Joan Basiuk; Simon Tanguay; Michael A S Jewett; Darrel Drachenberg
Journal:  Can Urol Assoc J       Date:  2016-07-12       Impact factor: 1.862

7.  Analyses of biomarkers of exposure to nephrotoxic mycotoxins in a cohort of patients with renal tumours.

Authors:  Frantisek Malir; Miroslav Louda; Vladimir Ostry; Jakub Toman; Nurshad Ali; Yann Grosse; Eva Malirova; Jaroslav Pacovsky; Darina Pickova; Milos Brodak; Annie Pfohl-Leszkowicz; Gisela H Degen
Journal:  Mycotoxin Res       Date:  2019-06-29       Impact factor: 3.833

Review 8.  Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach.

Authors:  Georgios Kallinikas; Helai Habib; Dimitrios Tsimiliotis; Evangelos Koutsokostas; Barna Bokor
Journal:  Int Urol Nephrol       Date:  2017-05-31       Impact factor: 2.370

9.  Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.

Authors:  M Neil Reaume; Naveen S Basappa; Lori Wood; Anil Kapoor; Georg A Bjarnason; Normand Blais; Rodney H Breau; Christina Canil; Patrick Cheung; Henry J Conter; Sebastien J Hotte; Claudio Jeldres; Michael A S Jewett; Pierre I Karakiewicz; Christian Kollmannsberger; Francois Patenaude; Alan So; Denis Soulières; Peter Venner; Phillippe Violette; Pawel Zalewski; Heather Chappell; Scott A North
Journal:  Can Urol Assoc J       Date:  2017-10       Impact factor: 1.862

10.  The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians.

Authors:  Jennifer Jones; Jaimin Bhatt; Jonathan Avery; Andreas Laupacis; Katherine Cowan; Naveen Basappa; Joan Basiuk; Christina Canil; Sohaib Al-Asaaed; Daniel Heng; Lori Wood; Dawn Stacey; Christian Kollmannsberger; Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2017-11-01       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.